Stroke is the third leading cause of death and the leading cause of adult disability in the United States. More adults are affected by stroke each year than Alzheimer's disease, multiple sclerosis, amyotrophic lateral sclerosis or Parkinson's disease. Hemorrhagic strokes represent the most severe subtypes of stroke. An estimated 40-50% of hemorrhagic stroke victims will die. Half of this mortality occurs in the first two days aftr the stroke making prevention of paramount importance. Familial aggregation and heritability studies strongly support the existence of genetic risk factors for non-lobar and lobar ICH independent of hypertension and apolipoprotein E status. The Genetic and Environmental Risk Factors for Hemorrhagic Stroke (GERFHS) and the Genetic Risks for Medication-Related Hemorrhagic Stroke (GOCHA) studies have led numerous advances in our understanding of the genetic epidemiology of hemorrhagic stroke and ICH in particular. Both studies were independently funded to perform genome wide association studies of ICH. Having completed enrollment, genotyping, analysis and finally meta-analysis, the studies have identified a genome-wide significant association with non-lobar ICH. The identification on Chr 1q22 overlies the identical region identified by the CHARGE consortium as association with the closely related phenotype of cerebral white matter disease. The finding overlies the polyamine modulating factor 1 (PMF1) gene, a novel location that was very unlikely to have been independently identified through candidate gene studies. Although PMF1 was initially identified as a cell growth regulator, it is the rate-limiting enzyme in the catabolic pathway of polyamine metabolism. Of particular interest to ICH and deep white matter hyperintensity and possibly to vascular cognitive impairment and small vessel ischemic disease, polyamines have been found to disrupt the blood brain barrier. We now propose to follow-up this seminal finding with deep sequencing of the candidate regions and gene expression studies over the regions in a collection of 500 non-lobar ICH cases and 300 frequency matched controls plus 700 publicly available controls. Unlike major genetic studies of the past decade, follow-up studies of specific regions (rather than genome-wide studies) require smaller sample sizes and a highly favorable cost. If successful, the current proposal will identify one of the first new risk factors for non-lobar and lobar ICH in a generation. These findings may have broad ranging impact on related phenotypes of vascular cognitive impairment, Alzheimer's disease and ischemic stroke.

Public Health Relevance

This proposal follows up on a long standing investment into the genetic underpinnings of stroke and in particular intracerebral hemorrhage. A novel genetic region of interest has been identified and replicated and the current proposal is to further understand these regions through deep sequencing and gene expression studies. The hope is that a new target for treatment and prevention of stroke may be identified.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01NS036695-18
Application #
9719914
Study Section
Neurological, Aging and Musculoskeletal Epidemiology (NAME)
Program Officer
Koenig, James I
Project Start
1997-09-12
Project End
2021-03-31
Budget Start
2019-04-01
Budget End
2020-03-31
Support Year
18
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Cincinnati
Department
Neurology
Type
Schools of Medicine
DUNS #
041064767
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Decker, Michael J; Jones, Karra A; Keating, Glenda L et al. (2018) Postnatal hypoxia evokes persistent changes within the male rat's dopaminergic system. Sleep Breath 22:547-554
Biffi, Alessandro; Kuramatsu, Joji B; Leasure, Audrey et al. (2017) Oral Anticoagulation and Functional Outcome after Intracerebral Hemorrhage. Ann Neurol 82:755-765
Falcone, Guido J; Woo, Daniel (2017) Genetics of Spontaneous Intracerebral Hemorrhage. Stroke 48:3420-3424
Phuah, Chia-Ling; Dave, Tushar; Malik, Rainer et al. (2017) Genetic variants influencing elevated myeloperoxidase levels increase risk of stroke. Brain 140:2663-2672
Woo, Daniel; Debette, Stephanie; Anderson, Christopher (2017) 20th Workshop of the International Stroke Genetics Consortium, November 3-4, 2016, Milan, Italy: 2016.036 ISGC research priorities. Neurol Genet 3:S12-S18
Rannikmäe, Kristiina; Sivakumaran, Vhinoth; Millar, Henry et al. (2017) COL4A2 is associated with lacunar ischemic stroke and deep ICH: Meta-analyses among 21,500 cases and 40,600 controls. Neurology 89:1829-1839
Anderson, Christopher D; Falcone, Guido J; Phuah, Chia-Ling et al. (2016) Genetic variants in CETP increase risk of intracerebral hemorrhage. Ann Neurol 80:730-740
Woo, Daniel; Kruger, Andrew J; Sekar, Padmini et al. (2016) Incontinence and gait disturbance after intraventricular extension of intracerebral hemorrhage. Neurology 86:905-11
Walsh, Kyle B; Woo, Daniel; Sekar, Padmini et al. (2016) Untreated Hypertension: A Powerful Risk Factor for Lobar and Nonlobar Intracerebral Hemorrhage in Whites, Blacks, and Hispanics. Circulation 134:1444-1452
Walsh, Kyle B; Sekar, Padmini; Langefeld, Carl D et al. (2015) Monocyte Count and 30-Day Case Fatality in Intracerebral Hemorrhage. Stroke 46:2302-4

Showing the most recent 10 out of 27 publications